Eplivanserin
- Generic Name
- Eplivanserin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H21FN2O2
- CAS Number
- 130579-75-8
- Unique Ingredient Identifier
- 3CO94WO6DJ
- Background
Eplivanserin has been used in trials studying the treatment of Sleep, Insomnia, Chronic Pain, Fibromyalgia, and Primary Insomnia, among others.
- Associated Conditions
- -
- Associated Therapies
- -
Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties
- First Posted Date
- 2008-12-09
- Last Posted Date
- 2016-03-07
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 637
- Registration Number
- NCT00805350
- Locations
- 🇵🇱
Sanofi-Aventis Administrative Office, Warszawa, Poland
Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-11-15
- Last Posted Date
- 2016-03-01
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 967
- Registration Number
- NCT00253968
- Locations
- 🇬🇧
Sanofi-Aventis Administrative Office, Guildford, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath